Synthetic lethality in MTAP-deleted tumors: a promising avenue through targeted disruption of the protein methylation pathway

Ann Oncol. 2024 Dec;35(12):1080-1082. doi: 10.1016/j.annonc.2024.09.009.

Authors

L Boscolo Bielo¹, G Curigliano²

Affiliations

¹ Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy.
² Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.

PMID: 39638473
DOI: 10.1016/j.annonc.2024.09.009

No abstract available

Publication types

Editorial